These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17085901)

  • 21. Importance of p53 for cancer onset and therapy.
    Haupt S; Haupt Y
    Anticancer Drugs; 2006 Aug; 17(7):725-32. PubMed ID: 16926623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [An overview of research on p53 tumor suppressor gene].
    Yokozaki H; Tahara E
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2181-6. PubMed ID: 9422058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor suppressor genes].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1265-73. PubMed ID: 8392829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
    Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
    Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The p53 saga: the good, the bad, and the dead.
    Oren M
    Harvey Lect; 2001-2002; 97():57-82. PubMed ID: 14562517
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor suppressor genes.
    Lee NK
    Head Neck; 1992; 14(5):407-14. PubMed ID: 1399577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of tumor suppression by LKB1.
    Vaahtomeri K; Mäkelä TP
    FEBS Lett; 2011 Apr; 585(7):944-51. PubMed ID: 21192934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioncogenes and human cancer.
    Carbone DP; Minna JD
    Annu Rev Med; 1993; 44():451-64. PubMed ID: 8476264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer. New link in a web of human genes.
    Wang JY
    Nature; 2000 May; 405(6785):404-5. PubMed ID: 10839519
    [No Abstract]   [Full Text] [Related]  

  • 30. Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.
    Falck J; Lukas C; Protopopova M; Lukas J; Selivanova G; Bartek J
    Oncogene; 2001 Sep; 20(39):5503-10. PubMed ID: 11571648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
    Pappas K; Xu J; Zairis S; Resnick-Silverman L; Abate F; Steinbach N; Ozturk S; Saal LH; Su T; Cheung P; Schmidt H; Aaronson S; Hibshoosh H; Manfredi J; Rabadan R; Parsons R
    Mol Cancer Res; 2017 Aug; 15(8):1051-1062. PubMed ID: 28483946
    [No Abstract]   [Full Text] [Related]  

  • 32. [How the elephant resists cancer or the arrival of a zombie gene].
    Weill JC
    Med Sci (Paris); 2019 May; 35(5):410-411. PubMed ID: 31115321
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor suppressor genes and human cancer.
    Brown MA
    Adv Genet; 1997; 36():45-135. PubMed ID: 9348653
    [No Abstract]   [Full Text] [Related]  

  • 34. p53: at the crossroads of molecular carcinogenesis and molecular epidemiology.
    Harris CC
    J Investig Dermatol Symp Proc; 1996 Apr; 1(2):115-8. PubMed ID: 9627703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pten, a protean tumor suppressor.
    Mutter GL
    Am J Pathol; 2001 Jun; 158(6):1895-8. PubMed ID: 11395362
    [No Abstract]   [Full Text] [Related]  

  • 36. [Molecular cancer epidemiology--the present status and future possibilities].
    Sakai T
    Nihon Eiseigaku Zasshi; 1996 Feb; 50(6):1036-46. PubMed ID: 8720930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
    Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
    Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TUSC7: A novel tumor suppressor long non-coding RNA in human cancers.
    Li N; Shi K; Li W
    J Cell Physiol; 2018 Sep; 233(9):6401-6407. PubMed ID: 29574722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling.
    Vazquez F; Sellers WR
    Biochim Biophys Acta; 2000 Feb; 1470(1):M21-35. PubMed ID: 10656987
    [No Abstract]   [Full Text] [Related]  

  • 40. The biology and clinical relevance of the PTEN tumor suppressor pathway.
    Sansal I; Sellers WR
    J Clin Oncol; 2004 Jul; 22(14):2954-63. PubMed ID: 15254063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.